{
  "id": 4481323,
  "title": "STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer",
  "url": "https://urgent.news/2026/08/30/stat-fda-approves-protagonist-and-takedas-drug-for-rare-blood-cancer",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-30T18:30:18.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/08/30/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}